Exact Mass: 476.0852

Exact Mass Matches: 476.0852

Found 14 metabolites which its exact mass value is equals to given mass value 476.0852, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid

4-{[13-chloro-10-(2,6-difluorophenyl)-3,5,9-triazatricyclo[9.4.0.0²,⁷]pentadeca-1(11),2,4,6,9,12,14-heptaen-4-yl]amino}benzoic acid

C25H15ClF2N4O2 (476.0852)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals COVID info from DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C281 - Antiviral Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

4-[(4-chloro-2-nitrophenyl)azo]-3-hydroxy-N-(2-methoxyphenyl)naphthalene-2-carboxamide

C24H17ClN4O5 (476.0887)

4-[6-(2,4-Dichlorophenyl)-4-methyl-2-oxo-5-phenylmethoxycarbonyl-1,6-dihydropyrimidin-3-yl]butanoic acid

C23H22Cl2N2O5 (476.0906)

N-[5-[(2,6-difluorophenyl)sulfonylamino]pentyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

C19H22F2N2O6S2 (476.0887)

6-Carboxynaphthofluorescein

C29H16O7 (476.0896)

5-Carboxynaphthofluorescein

C29H16O7 (476.0896)

allyl 3-O-(3-O-sulfo-beta-D-glucopyranuronosyl)-D-galactopyranoside

C15H24O15S (476.0836)

MLN8054

4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid

C25H15ClF2N4O2 (476.0852)

3-O-sulfo-beta-D-GlcA-(1->3)-1-O-allyl-D-Gal

C15H24O15S (476.0836)

A glycoside comprising 3-O-sulfo-D-glucose linked beta(1->3) to allyl D-galactoside.

Ravoxertinib hydrochloride

C21H19Cl2FN6O2 (476.0931)

Ravoxertinib hydrochloride (GDC-0994 hydrochloride) is an orally bioavailable inhibitor selective for ERK kinase activity with IC50 of 6.1 nM and 3.1 nM for ERK1 and ERK2, respectively.